Market Research

Orthotics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Best Price Guarantee Length Publisher Published Date SKU
from $4,995 250 Pages Fairfield Market Research June, 2024 FCSL18913947
Best Price Guarantee
Price from $4,995
Length 250 Pages
Publisher Fairfield Market Research
Published Date June, 2024
SKU FCSL18913947

Orthotics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global orthotics market is on a trajectory towards substantial growth, expanding at a robust CAGR over the next decade. According to Fairfield Market Research, North America led the regional market with a significant share. The market is expected to grow from $4.82 billion in 2024 to approximately $7.93 billion by 2031, driven by a 7.4% compound annual growth rate (CAGR).

Materials and Customization in Orthotic Products

Orthotic devices can be crafted from various materials, ranging from rigid to soft, based on individual health needs and symptoms. Physicians prescribe materials tailored to specific conditions, with common materials including plastic and carbon fiber known for their flexibility and cushioning properties. Orthotics can take many forms, from full shoe inserts similar to those found in sporting shoes to tiny heel inserts and ankle-foot supports with shoe inserts and calf wraps

Market Dynamics and Revenue Insights

Sales of orthotic devices have been significant within the global prosthetics and orthotics market. The orthotics market has experienced steady growth, driven by factors such as increasing life expectancy, the rising prevalence of lifestyle-related disorders, and various forms of arthritis.

Technological Innovations Fueling Market Expansion

Technological advancements present lucrative opportunities for market growth. Innovations such as 3D printing and digital technologies have revolutionized the manufacturing process of insoles, enhancing user comfort and features. Hospitals, in particular, have a high demand for insoles produced using these advanced techniques.

Opportunities and Challenges in the Marke

Government regulations globally are designed to ensure better treatment options for patients. The National Association for the Advancement of Orthotics & Prosthetics (NAAOP) emphasizes the importance of orthotics and prosthetics providers as vital healthcare professionals, especially during the COVID-19 pandemic. This recognition underscores the critical role of manufacturers and suppliers in patient care. However, potential negative effects of orthotic devices, such as exacerbating foot pain or causing postural alterations, deter some users. Additionally, the high cost of custom devices poses a significant barrier despite their numerous advantages over mass-produced alternatives.

Regional Market Insights

United States: Leading the Global Orthotics Market

The United States held a significant share of the global market, driven by the increasing number of patients with osteoporosis and the rising demand for treatment. The European Journal of Rheumatology reports a high prevalence of osteoporosis-related hip fractures, particularly among women in Europe and the United States.

Germany: High-Quality Healthcare and Awareness Drive Market Growth

Germany accounted for a notable share of the global market. The high quality of healthcare and increased awareness of health issues, including diabetes, contribute to market growth. According to the International Diabetes Federation, Germany has a significant prevalence of diabetes, posing risks for complications like diabetic foot ulcers.

Category-wise Market Insights

Custom Orthotics: Personalized Solutions for Individual Needs

Custom orthotics generated substantial revenue, with the segment expected to expand at a notable CAGR during the forecast period. Custom devices are preferred due to the varying sizes of feet and legs among individuals, with soft insoles being more popular than rigid ones.

Medical Applications: Leading Revenue Generation

Orthotics for medical purposes held a leading market share, with the segment projected to grow significantly. These devices are widely used to realign joints and reduce pain in affected areas.

Preferred Materials: Ethyl Vinyl Acetate (EVA)

Orthoses made from ethyl vinyl acetate (EVA) accounted for a high market share, expanding significantly. EVA materials are preferred for their control and shock absorption properties, easing foot and ankle pain by cushioning the foot and relieving pressure.

Key Market Developments

Ossur announced a collaboration with the Alfred Mann Foundation to explore mind-controlled prosthetic devices using implanted myoelectric sensors. Gait Up partnered with SIDAS, a global leader in the footwear retail market, to enhance their presence and offerings.

Competitive Analysis
• Aetrex Worldwide Inc.
• Bauerfeind AG
• Acor Orthopedic
• Amfit Inc.
• Blatchford Clinical Services
• Dr. Scholl’s (Bayer)
• Salts Techstep
• The Foot Lab
• Arden Orthotics Ltd.
• Bolton Bros
• Cascade Dafo Inc.
• Algeo Limited
• Tynor Orthotics Pvt. Ltd.
• Ottobock, A. Algeo Ltd.
• Hanger, Inc.
• Bauerfeind AG
• Birkenstock digital GmbH
• Foot Science International
• Groupe Gorgé
• DOLA – Digital Orthotics Laboratories Australia.
• Fillauer LLC,
• Ossur Corporate
• Basko Healthcare.
• DJO Global

Orthotics Industry Research Segmentation

By Product:
• Prefabricated
• Custom
Rigid/Function Orthotic Insoles
Soft/ Accommodative Insoles

By User Age Group:
• Adults
• Paediatrics

By Application:
• Sports & Athletics
• Medical
• Personal Comfort

By Material:
• Thermoplastics
• Polyethene Foams
• Leather
• Cork
• Composite Carbon Fibers
• EVA
• Gel
• Others

By User:
• Prefabricated
Adults
Paediatrics
• Custom
Adults
Paediatrics

By Distribution Channel:
• Drug Stores
• Hospitals & Specialty Clinics
• Online Stores
• Others

By Region:
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Medicated Skincare Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Medicated Skincare Market Outlook, 2018 – 2031
3.1. Global Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1.1. Pharmaceutical Grade Skincare
3.1.1.1.1.1. Vitamins
3.1.1.1.1.1.1. Serum
3.1.1.1.1.1.2. Creams
3.1.1.1.1.1.3. Masks
3.1.1.1.1.1.4. Lotions
3.1.1.1.1.2. Retinoids
3.1.1.1.1.2.1. Gels
3.1.1.1.1.2.2. Foam
3.1.1.1.1.2.3. Lotions
3.1.1.1.1.2.4. Creams
3.1.1.1.1.3. Salicylic Acid
3.1.1.1.1.3.1. Lotions
3.1.1.1.1.3.2. Gels
3.1.1.1.1.3.3. Soaps
3.1.1.1.1.3.4. Shampoo
3.1.1.1.1.3.5. Wash
3.1.1.1.1.3.6. Patches
3.1.1.1.1.4. Peptides
3.1.1.1.1.5. Growth Factors
3.1.1.1.1.6. Skin Disinfectants/Antiseptics
3.1.1.1.1.7. Solutions
3.1.1.1.1.8. Sprays
3.1.1.1.1.9. Skin Barrier Repair Products
3.1.1.1.2. Prescription(Rx) Skincare
3.1.1.1.2.1. Corticosteroids
3.1.1.1.2.2. Non-steroidal Drugs
3.1.1.1.2.3. Antifungal
3.1.1.1.2.4. Antibiotics
3.1.1.1.2.5. Immunosuppressants
3.1.1.1.2.6. Biologics
3.1.1.1.2.7. Others
3.2. Global Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Normal Skin
3.2.1.2. Dry Skin
3.2.1.3. Oily Skin
3.2.1.4. Combination Skin
3.2.1.5. Sensitive Skin
3.3. Global Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Acne
3.3.1.2. Scars
3.3.1.3. Anti-Aging
3.3.1.4. Skin Wrinkles
3.3.1.5. Stretch Marks
3.3.1.6. Freckles & Sun Spots
3.3.1.7. Dark Circles
3.3.1.8. Hyperpigmentation
3.3.1.9. Psoriasis
3.3.1.10. Eczema
3.3.1.11. Atopic Dermatitis
3.3.1.12. Rosacea
3.3.1.13. Melasma
3.3.1.14. Athlete's Foot?
3.3.1.15. Others
3.4. Global Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. Dermatology Clinics
3.4.1.2. Beauty & Wellness Centers
3.4.1.3. Medical Spa
3.4.1.4. Retail Pharmacy Chains
3.4.1.5. Drug Stores
3.4.1.6. Hypermarkets & Supermarkets
3.4.1.7. Mono Brand Stores
3.4.1.8. Specialty Stores
3.4.1.9. Online Sales Channels
3.5. Global Medicated Skincare Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Medicated Skincare Market Outlook, 2018 – 2031
4.1. North America Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1.1. Pharmaceutical Grade Skincare
4.1.1.1.1.1. Vitamins
4.1.1.1.1.1.1. Serum
4.1.1.1.1.1.2. Creams
4.1.1.1.1.1.3. Masks
4.1.1.1.1.1.4. Lotions
4.1.1.1.1.2. Retinoids
4.1.1.1.1.2.1. Gels
4.1.1.1.1.2.2. Foam
4.1.1.1.1.2.3. Lotions
4.1.1.1.1.2.4. Creams
4.1.1.1.1.3. Salicylic Acid
4.1.1.1.1.3.1. Lotions
4.1.1.1.1.3.2. Gels
4.1.1.1.1.3.3. Soaps
4.1.1.1.1.3.4. Shampoo
4.1.1.1.1.3.5. Wash
4.1.1.1.1.3.6. Patches
4.1.1.1.1.4. Peptides
4.1.1.1.1.5. Growth Factors
4.1.1.1.1.6. Skin Disinfectants/Antiseptics
4.1.1.1.1.7. Solutions
4.1.1.1.1.8. Sprays
4.1.1.1.1.9. Skin Barrier Repair Products
4.1.1.1.2. Prescription(Rx) Skincare
4.1.1.1.2.1. Corticosteroids
4.1.1.1.2.2. Non-steroidal Drugs
4.1.1.1.2.3. Antifungal
4.1.1.1.2.4. Antibiotics
4.1.1.1.2.5. Immunosuppressants
4.1.1.1.2.6. Biologics
4.1.1.1.2.7. Others
4.2. North America Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Normal Skin
4.2.1.2. Dry Skin
4.2.1.3. Oily Skin
4.2.1.4. Combination Skin
4.2.1.5. Sensitive Skin
4.3. North America Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Acne
4.3.1.2. Scars
4.3.1.3. Anti-Aging
4.3.1.4. Skin Wrinkles
4.3.1.5. Stretch Marks
4.3.1.6. Freckles & Sun Spots
4.3.1.7. Dark Circles
4.3.1.8. Hyperpigmentation
4.3.1.9. Psoriasis
4.3.1.10. Eczema
4.3.1.11. Atopic Dermatitis
4.3.1.12. Rosacea
4.3.1.13. Melasma
4.3.1.14. Athlete's Foot?
4.3.1.15. Others
4.4. North America Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. Dermatology Clinics
4.4.1.2. Beauty & Wellness Centers
4.4.1.3. Medical Spa
4.4.1.4. Retail Pharmacy Chains
4.4.1.5. Drug Stores
4.4.1.6. Hypermarkets & Supermarkets
4.4.1.7. Mono Brand Stores
4.4.1.8. Specialty Stores
4.4.1.9. Online Sales Channels
4.5. North America Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
4.5.1.2. U.S. Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
4.5.1.3. U.S. Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
4.5.1.4. U.S. Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.5.1.5. Canada Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
4.5.1.6. Canada Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
4.5.1.7. Canada Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
4.5.1.8. Canada Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Medicated Skincare Market Outlook, 2018 – 2031
5.1. Europe Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1.1. Pharmaceutical Grade Skincare
5.1.1.1.1.1. Vitamins
5.1.1.1.1.1.1. Serum
5.1.1.1.1.1.2. Creams
5.1.1.1.1.1.3. Masks
5.1.1.1.1.1.4. Lotions
5.1.1.1.1.2. Retinoids
5.1.1.1.1.2.1. Gels
5.1.1.1.1.2.2. Foam
5.1.1.1.1.2.3. Lotions
5.1.1.1.1.2.4. Creams
5.1.1.1.1.3. Salicylic Acid
5.1.1.1.1.3.1. Lotions
5.1.1.1.1.3.2. Gels
5.1.1.1.1.3.3. Soaps
5.1.1.1.1.3.4. Shampoo
5.1.1.1.1.3.5. Wash
5.1.1.1.1.3.6. Patches
5.1.1.1.1.4. Peptides
5.1.1.1.1.5. Growth Factors
5.1.1.1.1.6. Skin Disinfectants/Antiseptics
5.1.1.1.1.7. Solutions
5.1.1.1.1.8. Sprays
5.1.1.1.1.9. Skin Barrier Repair Products
5.1.1.1.2. Prescription(Rx) Skincare
5.1.1.1.2.1. Corticosteroids
5.1.1.1.2.2. Non-steroidal Drugs
5.1.1.1.2.3. Antifungal
5.1.1.1.2.4. Antibiotics
5.1.1.1.2.5. Immunosuppressants
5.1.1.1.2.6. Biologics
5.1.1.1.2.7. Others
5.2. Europe Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Normal Skin
5.2.1.2. Dry Skin
5.2.1.3. Oily Skin
5.2.1.4. Combination Skin
5.2.1.5. Sensitive Skin
5.3. Europe Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Acne
5.3.1.2. Scars
5.3.1.3. Anti-Aging
5.3.1.4. Skin Wrinkles
5.3.1.5. Stretch Marks
5.3.1.6. Freckles & Sun Spots
5.3.1.7. Dark Circles
5.3.1.8. Hyperpigmentation
5.3.1.9. Psoriasis
5.3.1.10. Eczema
5.3.1.11. Atopic Dermatitis
5.3.1.12. Rosacea
5.3.1.13. Melasma
5.3.1.14. Athlete's Foot?
5.3.1.15. Others
5.4. Europe Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Dermatology Clinics
5.4.1.2. Beauty & Wellness Centers
5.4.1.3. Medical Spa
5.4.1.4. Retail Pharmacy Chains
5.4.1.5. Drug Stores
5.4.1.6. Hypermarkets & Supermarkets
5.4.1.7. Mono Brand Stores
5.4.1.8. Specialty Stores
5.4.1.9. Online Sales Channels
5.5. Europe Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.5.1. Key Highlights
5.5.1.1. Germany Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.2. Germany Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.3. Germany Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.4. Germany Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.5. U.K. Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.6. U.K. Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.7. U.K. Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.8. U.K. Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.9. France Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.10. France Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.11. France Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.12. France Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.13. Italy Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.14. Italy Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.15. Italy Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.16. Italy Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.17. Turkey Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.18. Turkey Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.19. Turkey Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.20. Turkey Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.21. Russia Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.22. Russia Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.23. Russia Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.24. Russia Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.1.25. Rest of Europe Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
5.5.1.26. Rest of Europe Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
5.5.1.27. Rest of Europe Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
5.5.1.28. Rest of Europe Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Medicated Skincare Market Outlook, 2018 – 2031
6.1. Asia Pacific Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1.1. Pharmaceutical Grade Skincare
6.1.1.1.1.1. Vitamins
6.1.1.1.1.1.1. Serum
6.1.1.1.1.1.2. Creams
6.1.1.1.1.1.3. Masks
6.1.1.1.1.1.4. Lotions
6.1.1.1.1.2. Retinoids
6.1.1.1.1.2.1. Gels
6.1.1.1.1.2.2. Foam
6.1.1.1.1.2.3. Lotions
6.1.1.1.1.2.4. Creams
6.1.1.1.1.3. Salicylic Acid
6.1.1.1.1.3.1. Lotions
6.1.1.1.1.3.2. Gels
6.1.1.1.1.3.3. Soaps
6.1.1.1.1.3.4. Shampoo
6.1.1.1.1.3.5. Wash
6.1.1.1.1.3.6. Patches
6.1.1.1.1.4. Peptides
6.1.1.1.1.5. Growth Factors
6.1.1.1.1.6. Skin Disinfectants/Antiseptics
6.1.1.1.1.7. Solutions
6.1.1.1.1.8. Sprays
6.1.1.1.1.9. Skin Barrier Repair Products
6.1.1.1.2. Prescription(Rx) Skincare
6.1.1.1.2.1. Corticosteroids
6.1.1.1.2.2. Non-steroidal Drugs
6.1.1.1.2.3. Antifungal
6.1.1.1.2.4. Antibiotics
6.1.1.1.2.5. Immunosuppressants
6.1.1.1.2.6. Biologics
6.1.1.1.2.7. Others
6.2. Asia Pacific Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Normal Skin
6.2.1.2. Dry Skin
6.2.1.3. Oily Skin
6.2.1.4. Combination Skin
6.2.1.5. Sensitive Skin
6.3. Asia Pacific Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Acne
6.3.1.2. Scars
6.3.1.3. Anti-Aging
6.3.1.4. Skin Wrinkles
6.3.1.5. Stretch Marks
6.3.1.6. Freckles & Sun Spots
6.3.1.7. Dark Circles
6.3.1.8. Hyperpigmentation
6.3.1.9. Psoriasis
6.3.1.10. Eczema
6.3.1.11. Atopic Dermatitis
6.3.1.12. Rosacea
6.3.1.13. Melasma
6.3.1.14. Athlete's Foot?
6.3.1.15. Others
6.4. Asia Pacific Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. Dermatology Clinics
6.4.1.2. Beauty & Wellness Centers
6.4.1.3. Medical Spa
6.4.1.4. Retail Pharmacy Chains
6.4.1.5. Drug Stores
6.4.1.6. Hypermarkets & Supermarkets
6.4.1.7. Mono Brand Stores
6.4.1.8. Specialty Stores
6.4.1.9. Online Sales Channels
6.5. Asia Pacific Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.5.1. Key Highlights
6.5.1.1. China Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.2. China Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.3. China Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.4. China Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.5. Japan Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.6. Japan Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.7. Japan Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.8. Japan Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.9. South Korea Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.10. South Korea Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.11. South Korea Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.12. South Korea Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.13. India Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.14. India Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.15. India Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.16. India Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.17. Southeast Asia Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.18. Southeast Asia Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.19. Southeast Asia Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.20. Southeast Asia Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.1.21. Rest of Asia Pacific Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
6.5.1.22. Rest of Asia Pacific Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
6.5.1.23. Rest of Asia Pacific Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
6.5.1.24. Rest of Asia Pacific Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Medicated Skincare Market Outlook, 2018 – 2031
7.1. Latin America Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1.1. Pharmaceutical Grade Skincare
7.1.1.1.1.1. Vitamins
7.1.1.1.1.1.1. Serum
7.1.1.1.1.1.2. Creams
7.1.1.1.1.1.3. Masks
7.1.1.1.1.1.4. Lotions
7.1.1.1.1.2. Retinoids
7.1.1.1.1.2.1. Gels
7.1.1.1.1.2.2. Foam
7.1.1.1.1.2.3. Lotions
7.1.1.1.1.2.4. Creams
7.1.1.1.1.3. Salicylic Acid
7.1.1.1.1.3.1. Lotions
7.1.1.1.1.3.2. Gels
7.1.1.1.1.3.3. Soaps
7.1.1.1.1.3.4. Shampoo
7.1.1.1.1.3.5. Wash
7.1.1.1.1.3.6. Patches
7.1.1.1.1.4. Peptides
7.1.1.1.1.5. Growth Factors
7.1.1.1.1.6. Skin Disinfectants/Antiseptics
7.1.1.1.1.7. Solutions
7.1.1.1.1.8. Sprays
7.1.1.1.1.9. Skin Barrier Repair Products
7.1.1.1.2. Prescription(Rx) Skincare
7.1.1.1.2.1. Corticosteroids
7.1.1.1.2.2. Non-steroidal Drugs
7.1.1.1.2.3. Antifungal
7.1.1.1.2.4. Antibiotics
7.1.1.1.2.5. Immunosuppressants
7.1.1.1.2.6. Biologics
7.1.1.1.2.7. Others
7.2. Latin America Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Normal Skin
7.2.1.2. Dry Skin
7.2.1.3. Oily Skin
7.2.1.4. Combination Skin
7.2.1.5. Sensitive Skin
7.3. Latin America Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Acne
7.3.1.2. Scars
7.3.1.3. Anti-Aging
7.3.1.4. Skin Wrinkles
7.3.1.5. Stretch Marks
7.3.1.6. Freckles & Sun Spots
7.3.1.7. Dark Circles
7.3.1.8. Hyperpigmentation
7.3.1.9. Psoriasis
7.3.1.10. Eczema
7.3.1.11. Atopic Dermatitis
7.3.1.12. Rosacea
7.3.1.13. Melasma
7.3.1.14. Athlete's Foot?
7.3.1.15. Others
7.4. Latin America Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Dermatology Clinics
7.4.1.2. Beauty & Wellness Centers
7.4.1.3. Medical Spa
7.4.1.4. Retail Pharmacy Chains
7.4.1.5. Drug Stores
7.4.1.6. Hypermarkets & Supermarkets
7.4.1.7. Mono Brand Stores
7.4.1.8. Specialty Stores
7.4.1.9. Online Sales Channels
7.5. Latin America Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
7.5.1.2. Brazil Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
7.5.1.3. Brazil Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
7.5.1.4. Brazil Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.1.5. Mexico Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
7.5.1.6. Mexico Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
7.5.1.7. Mexico Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
7.5.1.8. Mexico Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.1.9. Argentina Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
7.5.1.10. Argentina Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
7.5.1.11. Argentina Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
7.5.1.12. Argentina Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.1.13. Rest of Latin America Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
7.5.1.14. Rest of Latin America Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
7.5.1.15. Rest of Latin America Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
7.5.1.16. Rest of Latin America Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Medicated Skincare Market Outlook, 2018 – 2031
8.1. Middle East & Africa Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1.1. Pharmaceutical Grade Skincare
8.1.1.1.1.1. Vitamins
8.1.1.1.1.1.1. Serum
8.1.1.1.1.1.2. Creams
8.1.1.1.1.1.3. Masks
8.1.1.1.1.1.4. Lotions
8.1.1.1.1.2. Retinoids
8.1.1.1.1.2.1. Gels
8.1.1.1.1.2.2. Foam
8.1.1.1.1.2.3. Lotions
8.1.1.1.1.2.4. Creams
8.1.1.1.1.3. Salicylic Acid
8.1.1.1.1.3.1. Lotions
8.1.1.1.1.3.2. Gels
8.1.1.1.1.3.3. Soaps
8.1.1.1.1.3.4. Shampoo
8.1.1.1.1.3.5. Wash
8.1.1.1.1.3.6. Patches
8.1.1.1.1.4. Peptides
8.1.1.1.1.5. Growth Factors
8.1.1.1.1.6. Skin Disinfectants/Antiseptics
8.1.1.1.1.7. Solutions
8.1.1.1.1.8. Sprays
8.1.1.1.1.9. Skin Barrier Repair Products
8.1.1.1.2. Prescription(Rx) Skincare
8.1.1.1.2.1. Corticosteroids
8.1.1.1.2.2. Non-steroidal Drugs
8.1.1.1.2.3. Antifungal
8.1.1.1.2.4. Antibiotics
8.1.1.1.2.5. Immunosuppressants
8.1.1.1.2.6. Biologics
8.1.1.1.2.7. Others
8.2. Middle East & Africa Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Normal Skin
8.2.1.2. Dry Skin
8.2.1.3. Oily Skin
8.2.1.4. Combination Skin
8.2.1.5. Sensitive Skin
8.3. Middle East & Africa Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Acne
8.3.1.2. Scars
8.3.1.3. Anti-Aging
8.3.1.4. Skin Wrinkles
8.3.1.5. Stretch Marks
8.3.1.6. Freckles & Sun Spots
8.3.1.7. Dark Circles
8.3.1.8. Hyperpigmentation
8.3.1.9. Psoriasis
8.3.1.10. Eczema
8.3.1.11. Atopic Dermatitis
8.3.1.12. Rosacea
8.3.1.13. Melasma
8.3.1.14. Athlete's Foot?
8.3.1.15. Others
8.4. Middle East & Africa Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. Dermatology Clinics
8.4.1.2. Beauty & Wellness Centers
8.4.1.3. Medical Spa
8.4.1.4. Retail Pharmacy Chains
8.4.1.5. Drug Stores
8.4.1.6. Hypermarkets & Supermarkets
8.4.1.7. Mono Brand Stores
8.4.1.8. Specialty Stores
8.4.1.9. Online Sales Channels
8.5. Middle East & Africa Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.5.1. Key Highlights
8.5.1.1. GCC Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
8.5.1.2. GCC Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
8.5.1.3. GCC Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
8.5.1.4. GCC Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.5. South Africa Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
8.5.1.6. South Africa Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
8.5.1.7. South Africa Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
8.5.1.8. South Africa Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.9. Egypt Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
8.5.1.10. Egypt Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
8.5.1.11. Egypt Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
8.5.1.12. Egypt Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.13. Nigeria Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
8.5.1.14. Nigeria Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
8.5.1.15. Nigeria Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
8.5.1.16. Nigeria Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.1.17. Rest of Middle East & Africa Medicated Skincare Market by Product, Value (US$ Bn), 2018 – 2031
8.5.1.18. Rest of Middle East & Africa Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 – 2031
8.5.1.19. Rest of Middle East & Africa Medicated Skincare Market by Indication, Value (US$ Bn), 2018 – 2031
8.5.1.20. Rest of Middle East & Africa Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Skin Type Heatmap
9.2. Manufacturer vs Skin Type Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. L'Oréal
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. GlaxoSmithKline PLC
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Bausch Health Companies
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Bayer AG
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. AbbVie Inc. (Allergan, Inc.)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Procter & Gamble
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Johnson & Johnson
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Galderma Laboratories, L.P.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Colgate-Palmolive Company (eltaMD)
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Kao Corporation
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. KOSE Corporation
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Jan Marini Skin Research, Inc.
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Perrigo Company PLC
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Merz Pharma GmbH & Co. KGaA
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Unilever PLC
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Estée Lauder
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Merz Pharma GmbH & Co. KGaA
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Natura
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

$4,995
$8,495
$10,600

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings